enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Duchenne muscular dystrophy - Wikipedia

    en.wikipedia.org/wiki/Duchenne_muscular_dystrophy

    Duchenne muscular dystrophy is a rare progressive disease that eventually affects all voluntary muscles and involves the heart and breathing muscles in later stages. Life expectancy is estimated to be around 25–26, [18] [59] but this varies. People born with Duchenne muscular dystrophy after 1990 have a median life expectancy of approximately ...

  3. Pfizer reports patient death in Duchenne gene therapy study - AOL

    www.aol.com/news/pfizer-reports-patient-death...

    (Reuters) -A young patient died due to cardiac arrest after receiving Pfizer's experimental gene therapy being tested in a mid-stage trial for a muscle-wasting disorder called Duchenne muscular ...

  4. Muscular dystrophy - Wikipedia

    en.wikipedia.org/wiki/Muscular_Dystrophy

    Duchenne muscular dystrophy: 310200: DMD: XR: Childhood Distal limbs progressing to generalised weakness, involving respiratory muscles The most common childhood form of muscular dystrophy, affects predominantly boys (mild symptoms may occur in female carriers). Characterised by progressive muscle wasting.

  5. Could This DMD Treatment Become a Blockbuster Drug? - AOL

    www.aol.com/2013/08/27/could-this-dmd-treatment...

    Duchenne muscular dystrophy, or DMD, is a muscle-wasting disease caused by a genetic mutation in the dystrophin gene -- the largest gene on the X chromosome -- which affects one in every 2,400 ...

  6. Physical therapy for Duchenne muscular dystrophy - Wikipedia

    en.wikipedia.org/wiki/Physical_therapy_for...

    Devices to help a person with duchenne muscular dystrophy stand are a common treatment approach. [3] Orthotic devices are used (as discussed above) and also specific standing devices such as standing frames, standing wheelchairs, and tables that have a tilt function.

  7. Deflazacort - Wikipedia

    en.wikipedia.org/wiki/Deflazacort

    The U.S. Food and Drug Administration approved deflazacort to treat people age five years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is a corticosteroid that works by decreasing inflammation and reducing the activity of the immune system. [5]

  8. Parents of baby suffering a rare, fatal disease create bucket ...

    www.aol.com/entertainment/2015-11-05-parents-of...

    Little Zailynn, a happy eight-month-old baby, has spinal muscular atrophy, a disease that is stealing her ability to Parents of baby suffering a rare, fatal disease create bucket list of memories ...

  9. Becker muscular dystrophy - Wikipedia

    en.wikipedia.org/wiki/Becker_muscular_dystrophy

    The progression of Becker muscular dystrophy is highly variable—much more so than Duchenne muscular dystrophy. There is also a form that may be considered as an intermediate between Duchenne and Becker MD (mild DMD or severe BMD). The severity of the disease may be indicated by the age of the patient at the onset of the disease. One study ...